Victory Capital Management
PAHC icon

Victory Capital Management’s Phibro Animal Health PAHC Stock Holding History

Victory Capital Management’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$380K Buy
+12,107
New +$511K ﹤0.01% 2121
2023
Q1 		– Sell
-86,988
Closed -$1.17M – 2666
2022
Q4 		$1.17M Sell
86,988
-231,633
-73% -$3.11M ﹤0.01% 1651
2022
Q3 		$4.23M Sell
318,621
-129,019
-29% -$2.23M ﹤0.01% 1282
2022
Q2 		$8.56M Buy
447,640
+9,800
+2% +$186K 0.01% 1114
2022
Q1 		$7.88M Buy
437,840
+145,990
+50% +$2.95M 0.01% 1184
2021
Q4 		$5.96M Buy
291,850
+38,171
+15% +$815K 0.01% 1285
2021
Q3 		$5.46M Buy
253,679
+24,040
+10% +$579K 0.01% 1308
2021
Q2 		$6.63M Buy
229,639
+47,940
+26% +$1.3M 0.01% 1251
2021
Q1 		$4.43M Buy
181,699
+171,251
+1,639% +$3.87M ﹤0.01% 1383
2020
Q4 		$203K Sell
10,448
-18,582
-64% -$342K ﹤0.01% 2371
2020
Q3 		$505K Sell
29,030
-702
-2% -$15K ﹤0.01% 1951
2020
Q2 		$781K Sell
29,732
-28,066
-49% -$697K ﹤0.01% 1831
2020
Q1 		$1.4M Buy
57,798
+3,907
+7% +$95.5K ﹤0.01% 1452
2019
Q4 		$1.34M Buy
53,891
+6,746
+14% +$157K ﹤0.01% 1654
2019
Q3 		$1.01M Buy
47,145
+42,704
+962% +$1.17M ﹤0.01% 1700
2019
Q2 		$141K Sell
4,441
-7,713
-63% -$242K ﹤0.01% 1504
2019
Q1 		$401K Buy
12,154
+1,398
+13% +$43.5K ﹤0.01% 1363
2018
Q4 		$346K Buy
10,756
+419
+4% +$15.8K ﹤0.01% 1445
2018
Q3 		$443K Buy
10,337
+2,242
+28% +$106K ﹤0.01% 1455
2018
Q2 		$373K Buy
8,095
+1,108
+16% +$49.1K ﹤0.01% 1453
2018
Q1 		$277K Buy
6,987
+1,304
+23% +$48.3K ﹤0.01% 1494
2017
Q4 		$190K Buy
5,683
+493
+9% +$17.5K ﹤0.01% 1584
2017
Q3 		$192K Sell
5,190
-190
-4% -$7.13K ﹤0.01% 1546
2017
Q2 		$199K Buy
5,380
+807
+18% +$26.3K ﹤0.01% 1452
2017
Q1 		$129K Buy
4,573
+2,021
+79% +$57K ﹤0.01% 1560
2016
Q4 		$75K Sell
2,552
-62
-2% -$1.69K ﹤0.01% 1644
2016
Q3 		$71K Buy
2,614
+289
+12% +$6.54K ﹤0.01% 1644
2016
Q2 		$43K Buy
2,325
+1,013
+77% +$21.1K ﹤0.01% 1543
2016
Q1 		$35K Buy
+1,312
New +$37.6K ﹤0.01% 1526

Other funds holding PAHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Victory Capital Management's PAHC Position: Q2 2026 in Review

Victory Capital Management opened a new position in Phibro Animal Health (PAHC) in Q2 2026: 12,107 shares worth $380K. The stake represents ﹤0.01% of the portfolio and ranks #2121 among its holdings. This is a return to the name: Victory Capital Management previously reported a position in PAHC as recently as Q4 2022.

Victory Capital Management first reported a position in PAHC in Q1 2016 and has held it in 29 quarters since. The position peaked at $8.56M in Q2 2022. 208 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

  • Victory Capital Management held 12,107 shares of Phibro Animal Health worth $380K as of Q2 2026.
  • Phibro Animal Health was a new Victory Capital Management position in Q2 2026.
  • Phibro Animal Health made up ﹤0.01% of Victory Capital Management's portfolio in Q2 2026, its #2121 holding.
  • Victory Capital Management first reported a position in Phibro Animal Health in Q1 2016 and has held it in 29 quarters since.
  • Victory Capital Management's Phibro Animal Health position peaked at $8.56M in Q2 2022.
  • 208 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on Victory Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.